Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are metastatic testicular tumors curable with high-dose chemotherapy and stem-cell rescue?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fossa SD et al. (1999) Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 80: 1392–1399

    Article  CAS  Google Scholar 

  2. De Giorgi U et al. (2002) The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients. Haematologica 87: 95–104

    CAS  PubMed  Google Scholar 

  3. International Germ Cell Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15: 594–603

  4. Motzer RJ et al. (2007) Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25: 247–256

    Article  CAS  Google Scholar 

  5. Pico JL et al. (2005) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16: 1152–1159

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice. The authors are members and wrote this article on behalf of the Italian Germ Cell Cancer Group (IGG) and Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Rosti.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosti, G., De Giorgi, U. & Pedrazzoli, P. Are metastatic testicular tumors curable with high-dose chemotherapy and stem-cell rescue?. Nat Rev Clin Oncol 5, 126–127 (2008). https://doi.org/10.1038/ncponc1018

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1018

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing